A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
Rothenberg ML, Cox JV, DeVore RF, Hainsworth JD, Pazdur R, Rivkin SE, Macdonald JS, Geyer CE Jr, Sandbach J, Wolf DL, Mohrland JS, Elfring GL, Miller LL, Von Hoff DD.
Rothenberg ML, et al. Among authors: rivkin se.
Cancer. 1999 Feb 15;85(4):786-95.
Cancer. 1999.
PMID: 10091755
Clinical Trial.